Watkins Tim Insider Trading Activity
Watkins Tim has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
CTNM is the most-traded position with 5 trades. The largest single transaction was a sale of CTNM for $174K on Jun 30, 2026.
Performance Scorecard
Forward stock performance after each transaction by Watkins Tim. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -6.0% | 25% | 4 |
| 90 days | — | +9.5% | 75% | 4 |
| 120 days | — | +0.1% | 50% | 4 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersCTNM · Contineum Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Watkins Tim bought and sold CTNM.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jun 30, 2026 | CTNM | Sell | 10,833 | $16.02 | $174K | −54.7% | CMO & Head of Development | |
Mar 2, 2026 | CTNM | Sell | 3,611 | $15.02 | $54K | −100.0% | CMO & Head of Development | |
Jan 28, 2026 | CTNM | Sell | 2,800 | $14.09 | $39K | −77.5% | CMO & Head of Development | |
Jan 28, 2026 | CTNM | Sell | 811 | $14.48 | $12K | −100.0% | CMO & Head of Development | |
Dec 29, 2025 | CTNM | Sell | 3,611 | $12.06 | $44K | −100.0% | CMO & Head of Development |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 5 | $323K |
Other insiders at Contineum Therapeutics, Inc.
2 other tracked filers at CTNM.